<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">Health</journal-id><journal-title-group><journal-title>Health</journal-title></journal-title-group><issn pub-type="epub">1949-4998</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/health.2019.116051</article-id><article-id pub-id-type="publisher-id">Health-92862</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Factors Associated with Asymptomatic Proteinuria in Adult Nigerians. A Community-Based Study
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Obinna</surname><given-names>Onodugo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Adikaibe</surname><given-names>Ezeala-Adikaibe</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Casmir</surname><given-names>Orjioke</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pauline</surname><given-names>Nkiruka Onodugo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Uchenna</surname><given-names>Nkemdilim Ijoma</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Peter</surname><given-names>Chime</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nkeiruka</surname><given-names>Mbadiwe</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chinwe</surname><given-names>Onyekonwu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Obumneme</surname><given-names>Benneth Anyim</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ijeoma</surname><given-names>Nnenne Obumneme-Anyim</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ekenechukwu</surname><given-names>Young</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chidimma</surname><given-names>Brenda Nwatu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Julius</surname><given-names>Uwabunkeonye Okoye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Monday</surname><given-names>Ume Nwobodo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Medicine, University of Nigeria Teaching Hospital, Enugu, Nigeria</addr-line></aff><aff id="aff2"><addr-line>Department of Medicine, Enugu State University Teaching Hospital, Enugu, Nigeria</addr-line></aff><aff id="aff3"><addr-line>Department of Pediatrics, University of Nigeria Teaching Hospital, Enugu, Nigeria</addr-line></aff><pub-date pub-type="epub"><day>03</day><month>06</month><year>2019</year></pub-date><volume>11</volume><issue>06</issue><fpage>609</fpage><lpage>620</lpage><history><date date-type="received"><day>29,</day>	<month>April</month>	<year>2019</year></date><date date-type="rev-recd"><day>31,</day>	<month>May</month>	<year>2019</year>	</date><date date-type="accepted"><day>3,</day>	<month>June</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: Early detection of proteinuria is early detection is a cost-effective method of assessing individuals with and without risk factors for chronic renal disease. Proteinuria is common in adults and may present a clinical challenge in the absence of obvious renal disease or risk factors especially in the tropics. Few studies in Nigeria have assessed the prevalence of proteinuria in adults using the dipstick method. The aim of this study was to document the prevalence of proteinuria among residents of a community in Enugu, south east Nigeria. 
  Methods: This was a cross-sectional descriptive study carried out in an isolated urban slum settlement in Enugu, south east Nigeria. Dipstick testing of freshly voided early morning mid-stream urine samples was done to detect proteinuria. For database management and statistical analyses, SPSS version 23 was used. 
  Results: A total of 262 individuals were recruited for the study, 165 (63%) females and 97 (37%) males. The participants’ age ranged from 18 to 90 years, averaging 43.7 &#177; 15.5. Trace amounts of protein were detected in urine samples of 225 (85.9%) individuals. Significant proteinuria was detected in 3.8% of the participants and was significantly higher 40 - 49-year-olds (6%). p = 0.02 and 0.02 respectively. Significant correlates of proteinuria were lower diastolic blood pressure and current tobacco use. Lower body mass index weakly correlated with proteinuria. 
  Conclusion: The prevalence of significant early morning proteinuria in a community-based study in Enugu was 3.8%. Significant correlates of proteinuria included low diastolic blood pressure and tobacco use. Community based awareness programs targeted at prevention of chronic renal diseases should be incorporated in public health programs.
 
</p></abstract><kwd-group><kwd>Proteinuria</kwd><kwd> Chronic Renal Disease</kwd><kwd> Risk Factors</kwd><kwd> Nigeria</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The presence of detectable protein in urine (proteinuria) is common in adults and especially in the elderly [<xref ref-type="bibr" rid="scirp.92862-ref1">1</xref>] and may present a clinical challenge for physicians in the absence of obvious renal disease especially in the tropics. Apart from established causes, proteinuria may be seen in malaria and other common tropical infections [<xref ref-type="bibr" rid="scirp.92862-ref2">2</xref>] and tobacco users [<xref ref-type="bibr" rid="scirp.92862-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref5">5</xref>]. Proteinuria is an established predictor of developing renal disease. It has been associated with a two-fold increase in the risk of developing hypertension in renal disease [<xref ref-type="bibr" rid="scirp.92862-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref2">2</xref>]. It is also an indirect marker for arterial diseases and a risk factor for dementia, stroke as well as poor prognostic factor in cardiovascular disease [<xref ref-type="bibr" rid="scirp.92862-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref9">9</xref>]. Using proteinuria as the first step in screening for renal disease in both subjects with or without risk factors for chronic renal disease is an established protocol in hospital practice [<xref ref-type="bibr" rid="scirp.92862-ref10">10</xref>] , however, the same cannot be said of the general population. A study done about 2 decades ago in the US considered early detection of urine protein not to be cost-effective in individuals without risk factors [<xref ref-type="bibr" rid="scirp.92862-ref11">11</xref>] , nevertheless, screening for proteinuria is considered to be cheap in some developing countries [<xref ref-type="bibr" rid="scirp.92862-ref12">12</xref>] where it remains a cheap but high yielding investigation for patients presenting in crowded general adult medical outpatient clinics. The use of early morning urine sample is thought to achieve greater consistency in the assessment of proteinuria but it has not achieved widespread acceptance [<xref ref-type="bibr" rid="scirp.92862-ref13">13</xref>].</p><p>Causes and risk factors for proteinuria in adults and the elderly are numerous and include hypertension, obesity, smoking and elevated systolic blood pressure [<xref ref-type="bibr" rid="scirp.92862-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref14">14</xref>]. Generally, it has been estimated that about 5% of the general population would develop proteinuria, 15% of whom who may develop renal disease [<xref ref-type="bibr" rid="scirp.92862-ref15">15</xref>]. Few studies in Nigeria have assessed the prevalence of proteinuria in adults [<xref ref-type="bibr" rid="scirp.92862-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref19">19</xref>] using the dipstick method. Ulasi et al. [<xref ref-type="bibr" rid="scirp.92862-ref16">16</xref>] reported a 19% prevalence of proteinuria in a community survey while Arogundade et al. [<xref ref-type="bibr" rid="scirp.92862-ref17">17</xref>] and Abene et al. [<xref ref-type="bibr" rid="scirp.92862-ref18">18</xref>] reported a prevalence of 29.7% and 8.4% respectively. In a study from the northern part of Nigeria, a prevalence of 20.2% was found among undergraduates [<xref ref-type="bibr" rid="scirp.92862-ref19">19</xref>]. Studies outside the country have reported lower prevalences among the general adult population [<xref ref-type="bibr" rid="scirp.92862-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref24">24</xref>]. Screening for proteinuria in the general populace has frequently been used to detect cases of possible chronic renal disease in Nigeria [<xref ref-type="bibr" rid="scirp.92862-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref19">19</xref>] because of availability, reliability and ease of use. The aim of this study was to document the prevalence of proteinuria among residents of a community in Enugu, south east Nigeria.</p></sec><sec id="s2"><title>2. Methods</title><p>This was a cross-sectional descriptive study carried out in an isolated urban slum settlement (Agu-Abor) in Enugu, the capital of Enugu State, south east Nigeria. Full description of the study protocol had been documented previously [<xref ref-type="bibr" rid="scirp.92862-ref25">25</xref>]. The inhabitants were surveyed over a 4-week period (August 12-September 9, 2013). This study was approved by the ethics committee of the University of Nigeria Teaching Hospital Ituku/Ozalla.</p><sec id="s2_1"><title>2.1. Study Protocol</title><p>A semi structured questionnaire was used to collect data on selected socio-demographic characteristics, lifestyle behaviors and medical history. Cases of hypertension, diabetes, epilepsy and other medical conditions were recorded based on previously published protocol. Substance use such as tobacco and alcohol in the past 4 weeks were also documented. Current use of alcohol was defined as use of any or all alcoholic beverages in the past 4 weeks. Level of education was the individual’s highest formal educational attainment based on the Nigerian school system.</p><sec id="s2_1_1"><title>2.1.1. Sample Collection and Dipstick Testing</title><p>Urine samples were collected from randomly selected consenting adults 18 years and above. Freshly voided early morning mid-stream urine samples were collected at home by the participants after adequate sensitization on how the collection should be done. Samples were tested as early as 8-9 am the following day. Urine samples were collected from consecutive consenting adults 18 years and above. The urinalysis results of pregnant women (one person) and participants who had history of renal disease (none) were excluded from the final analysis. Dipstick testing was done using URS 11 urine analysis strips. Urine analysis strips were immersed in urine sample, quickly removed and read immediately by comparing the color change with that provided on the container chat. Excess urine was removed by running the edge of the strip against the rim of the container. Finally, the strip was held horizontally and compared to the color chart on the bottle label. The protein chart was read immediately in less than 60 seconds after dipping. The test kit is a reagent strip impregnated with a 0.1% m/m tetrabromphenol blue; 97.4% w/w buffer; 2.5% w/w non-reactive buffer and is based on the protein-error-of-indicators principle. A color matching any block greater than trace indicates significant proteinuria. The sensitivity of reagent strips is only 15% to 30% with a specificity of 97% to 100%. The dipstick provides a qualitative estimate of the degree of proteinuria and not absolute amounts. For the purpose of this study, samples with urine PH of 7 were regarded as false positive and were excluded. Participants were interviewed by teams of research assistants using the research questionnaire and results of the urine tests noted.</p></sec><sec id="s2_1_2"><title>2.1.2. Inclusion and Exclusion Criteria</title><p>All consenting adults living in the locality were included. Pregnant women, suspected cases of urinary tract infection and past medical history of renal disease were excluded.</p></sec></sec><sec id="s2_2"><title>2.2. Sample Size</title><p>The minimum sample size was calculated using the Cochran Equation [<xref ref-type="bibr" rid="scirp.92862-ref26">26</xref>] ,</p><p>N = Z 2 ( p q ) / e 2</p><p>where: N = required sample size, Z = 1.96, p = 0.019 [<xref ref-type="bibr" rid="scirp.92862-ref16">16</xref>] , q = 0.81 and e<sup>2</sup> = error limit of 0.05.</p><p>N = ( 1.96 ) 2 ( 0.019 &#215; 0.81 ) / 0.0025 = 236 . Assuming 10% attrition rate an extra 40 participants were added giving a minimum sample size of 261 urine samples.</p></sec><sec id="s2_3"><title>2.3. Statistical Methods</title><p>For database management and statistical analyses, we used the SPSS version 23 (IBM Corporation, New York, USA). Data were presented in tables and figures. For continuous variables, mean values and standard deviation were calculated. Rates were expressed as percentages. Categorical values were compared using the Chi-Square test. Mean age was compared using the independent t-test. In all, p-value &lt; 0.05 was regarded as statistically significant. Conclusions were drawn at 95% confidence interval.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. General Characteristics of the Sample Population</title><p>Out of 298 samples that were collected, 262 (87.9%) had complete data and were analysed. Gender distribution showed that 165 (63%) were females and 97 (37%) were males with a male to female ratio of 1:1.7. The participants’ age ranged from 18 to 90 years, averaging 43.7 &#177; 15.5. Males were older than females by about 9 years (mean age: 49.5 vs 40.4 years, p &lt; 0.01). The peak age group of males and females was 50 - 69 and 20 - 29 years (40.2% and 49.7% respectively) (<xref ref-type="table" rid="table1">Table 1</xref>). Most participants achieved more than primary school education (54.2%) and more than 63% were employed in one trade or the other. The mean systolic and diastolic pressure and relevant reported medical history are shown in <xref ref-type="table" rid="table1">Table 1</xref>. Tobacco and alcohol use within the preceding 4 weeks were 37 (14.2%) and 172 (65.6%) and significantly more prevalent in males, p &lt; 0.01 respectively (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s3_2"><title>3.2. Proteinuria</title><p>Trace amounts of protein were detected in urine samples of 225 (85.9%) individuals (<xref ref-type="fig" rid="fig1">Figure 1</xref>). One or more pulses of protein (significant proteinuria) was detected in 3.8% of the samples. The distribution of significant proteinuria is shown in <xref ref-type="table" rid="table2">Table 2</xref>. It was more prevalent in 40 - 49-year-olds (6%) and tobacco user. Individuals with significant proteinuria also had lower mean diastolic blood pressure. Significant correlates of proteinuria (0 =no/trace proteinuria, 1 = significant proteinuria) were lower diastolic blood pressure and current tobacco use, p = 0.02 and 0.02 respectively. Lower body mass index weakly correlated with proteinuria, p = 0.07 (<xref ref-type="table" rid="table3">Table 3</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Characteristics of participants</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Characteristic</th><th align="center" valign="middle" >Female</th><th align="center" valign="middle" >Male</th><th align="center" valign="middle" >Total</th><th align="center" valign="middle" >p-value</th></tr></thead><tr><td align="center" valign="middle" >N (%)</td><td align="center" valign="middle" >165 (63)</td><td align="center" valign="middle" >97 (37)</td><td align="center" valign="middle" >262 (100)</td><td align="center" valign="middle" >&lt;0.01</td></tr><tr><td align="center" valign="middle" >Age, Years (mean, sd)</td><td align="center" valign="middle" >40.4 (13.5)</td><td align="center" valign="middle" >49.5 (16.9)</td><td align="center" valign="middle" >43.7 (15.5)</td><td align="center" valign="middle" >&lt;0.01</td></tr><tr><td align="center" valign="middle" >Body Mass Index, kg/m<sup>2</sup> (sd)</td><td align="center" valign="middle" >26.9 (5.7)</td><td align="center" valign="middle" >23.8 (4.1)</td><td align="center" valign="middle" >25.8 (5.4)</td><td align="center" valign="middle" >&lt;0.01</td></tr><tr><td align="center" valign="middle" >Age Group, N (%)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >20 - 29</td><td align="center" valign="middle" >42 (25.5)</td><td align="center" valign="middle" >19 (19.6)</td><td align="center" valign="middle" >61 (23.3)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >30 - 39</td><td align="center" valign="middle" >40 (24.2)</td><td align="center" valign="middle" >10 (10.3)</td><td align="center" valign="middle" >50 (19.1)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >40 - 49</td><td align="center" valign="middle" >35 (21.2)</td><td align="center" valign="middle" >15 (15.5)</td><td align="center" valign="middle" >50 (19.1)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >50 - 59</td><td align="center" valign="middle" >23 (13.9)</td><td align="center" valign="middle" >18 (18.6)</td><td align="center" valign="middle" >41 (15.6)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >60 - 69</td><td align="center" valign="middle" >18 (10.9)</td><td align="center" valign="middle" >20 (20.6)</td><td align="center" valign="middle" >38 (14.5)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >≥70</td><td align="center" valign="middle" >7 (4.2)</td><td align="center" valign="middle" >15 (15.5)</td><td align="center" valign="middle" >22 (8.4)</td><td align="center" valign="middle" >&lt;0.01</td></tr><tr><td align="center" valign="middle" >Level of Education</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >None/Primary, N (%)</td><td align="center" valign="middle" >68 (41.2)</td><td align="center" valign="middle" >52 (53.6)</td><td align="center" valign="middle" >293 (45.8)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Secondary and Above, N (%)</td><td align="center" valign="middle" >97 (58.8)</td><td align="center" valign="middle" >45 (46.4)</td><td align="center" valign="middle" >142 (54.2)</td><td align="center" valign="middle" >0.05</td></tr><tr><td align="center" valign="middle" >Occupation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Business*</td><td align="center" valign="middle" >80 (48.5)</td><td align="center" valign="middle" >16 (16.5)</td><td align="center" valign="middle" >96 (36.6)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Artisans</td><td align="center" valign="middle" >10 (6.1)</td><td align="center" valign="middle" >29 (29.9)</td><td align="center" valign="middle" >39 (14.9)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Office Workers</td><td align="center" valign="middle" >15 (9.1)</td><td align="center" valign="middle" >15 (15.5)</td><td align="center" valign="middle" >30 (11.5)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Students</td><td align="center" valign="middle" >16 (9.7)</td><td align="center" valign="middle" >10 (10.3)</td><td align="center" valign="middle" >26 (9.9)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Unemployed</td><td align="center" valign="middle" >19 (11.5)</td><td align="center" valign="middle" >8 (8.2)</td><td align="center" valign="middle" >27 (10.3)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Retired and Others</td><td align="center" valign="middle" >25 (15.2)</td><td align="center" valign="middle" >19 (19.6)</td><td align="center" valign="middle" >44 (16.8)</td><td align="center" valign="middle" >&lt;0.01</td></tr><tr><td align="center" valign="middle" >Blood Pressure</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Systolic Pressure, mm/Hg (mean sd)</td><td align="center" valign="middle" >132.3 (24.7)</td><td align="center" valign="middle" >136.6 (23.8)</td><td align="center" valign="middle" >133.9 (24.3)</td><td align="center" valign="middle" >0.16</td></tr><tr><td align="center" valign="middle" >Diastolic Pressure, mm/Hg (mean sd)</td><td align="center" valign="middle" >82.4 (16.4)</td><td align="center" valign="middle" >82.4 (14.7)</td><td align="center" valign="middle" >82.4 (15.7)</td><td align="center" valign="middle" >0.96</td></tr><tr><td align="center" valign="middle" >Glucose, mg/dL (mean sd)</td><td align="center" valign="middle" >92.7 (23.8)</td><td align="center" valign="middle" >95.9 (30.7)</td><td align="center" valign="middle" >93.4 (26.5)</td><td align="center" valign="middle" >0.37</td></tr><tr><td align="center" valign="middle" >Lifestyle</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Current Tobacco Use, N (%)</td><td align="center" valign="middle" >10 (6.1)</td><td align="center" valign="middle" >27 (28.1)</td><td align="center" valign="middle" >37 (14.2)</td><td align="center" valign="middle" >&lt;0.01</td></tr><tr><td align="center" valign="middle" >Current Alcohol Use, N (%)</td><td align="center" valign="middle" >96 (58.2)</td><td align="center" valign="middle" >76 (78.2)</td><td align="center" valign="middle" >172 (65.6)</td><td align="center" valign="middle" >&lt;0.01</td></tr><tr><td align="center" valign="middle" >Medical History</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hypertension, N (%)</td><td align="center" valign="middle" >35 (21.2)</td><td align="center" valign="middle" >23 (23.7)</td><td align="center" valign="middle" >58 (22.1)</td><td align="center" valign="middle" >0.64</td></tr><tr><td align="center" valign="middle" >Diabetes, N (%)</td><td align="center" valign="middle" >5 (3)</td><td align="center" valign="middle" >11 (11.3)</td><td align="center" valign="middle" >16 (6.1)</td><td align="center" valign="middle" >0.65</td></tr><tr><td align="center" valign="middle" >Stroke, N (%)</td><td align="center" valign="middle" >2 (1.2)</td><td align="center" valign="middle" >3 (3.1)</td><td align="center" valign="middle" >5 (1.9)</td><td align="center" valign="middle" >0.28</td></tr><tr><td align="center" valign="middle" >Arthritis, N (%)</td><td align="center" valign="middle" >25 (15.2)</td><td align="center" valign="middle" >25 (25.8)</td><td align="center" valign="middle" >50 (19.1)</td><td align="center" valign="middle" >0.04</td></tr><tr><td align="center" valign="middle" >Primary Sources of Medications</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hospital or Pharmacy</td><td align="center" valign="middle" >132 (80)</td><td align="center" valign="middle" >79 (81.4)</td><td align="center" valign="middle" >211 (80.5)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Open Market</td><td align="center" valign="middle" >33 (20)</td><td align="center" valign="middle" >18 (18.6)</td><td align="center" valign="middle" >51 (19.5)</td><td align="center" valign="middle" >0.78</td></tr></tbody></table></table-wrap><p>p-values are for the sex differences.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of significant proteinuria</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Characteristic**</th><th align="center" valign="middle" >None/Trace</th><th align="center" valign="middle" >One-Two Pluses</th><th align="center" valign="middle" >p-value</th></tr></thead><tr><td align="center" valign="middle" >N</td><td align="center" valign="middle" >252 (96.2)</td><td align="center" valign="middle" >10 (3.8)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Males</td><td align="center" valign="middle" >93 (95.9)</td><td align="center" valign="middle" >4 (4.1)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Females</td><td align="center" valign="middle" >159 (96.4)</td><td align="center" valign="middle" >6 (3.6)</td><td align="center" valign="middle" >0.84</td></tr><tr><td align="center" valign="middle" >Age (Mean, sd)</td><td align="center" valign="middle" >43.7 (15.5)</td><td align="center" valign="middle" >44.2 (15.3)</td><td align="center" valign="middle" >0.93</td></tr><tr><td align="center" valign="middle" >Age Group, N (%)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >20 - 29</td><td align="center" valign="middle" >59 (96.7)</td><td align="center" valign="middle" >2 (3.3)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >30 - 39</td><td align="center" valign="middle" >48 (96)</td><td align="center" valign="middle" >2 (4)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >40 - 49</td><td align="center" valign="middle" >47 (94)</td><td align="center" valign="middle" >3 (6)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >50 - 59</td><td align="center" valign="middle" >41 (100)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >60 - 69</td><td align="center" valign="middle" >36 (94.7)</td><td align="center" valign="middle" >2 (5.3)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >≥70</td><td align="center" valign="middle" >21 (95.5)</td><td align="center" valign="middle" >1 (4.5)</td><td align="center" valign="middle" >0.77*</td></tr><tr><td align="center" valign="middle" >BMI (mean, sd)</td><td align="center" valign="middle" >25.9 (5.4)</td><td align="center" valign="middle" >22.8 (3.3)</td><td align="center" valign="middle" >0.07</td></tr><tr><td align="center" valign="middle" >SBP (mean, sd)</td><td align="center" valign="middle" >134.1 (24.5)</td><td align="center" valign="middle" >128.6 (21.2)</td><td align="center" valign="middle" >0.49</td></tr><tr><td align="center" valign="middle" >DBP (mean, sd)</td><td align="center" valign="middle" >82.8 (15.8)</td><td align="center" valign="middle" >71.3 (9.2)</td><td align="center" valign="middle" >0.02</td></tr><tr><td align="center" valign="middle" >FBS (mean sd)</td><td align="center" valign="middle" >94.2 (26.9)</td><td align="center" valign="middle" >86.7 (12)</td><td align="center" valign="middle" >0.38</td></tr><tr><td align="center" valign="middle" >Medical History, N (%)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" >10 (4.1)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.41*</td></tr><tr><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >8 (3.9)</td><td align="center" valign="middle" >2 (3.4)</td><td align="center" valign="middle" >0.87*</td></tr><tr><td align="center" valign="middle" >Stroke</td><td align="center" valign="middle" >10 (3.9)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.65*</td></tr><tr><td align="center" valign="middle" >Substance Use, N (%)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Alcohol Use</td><td align="center" valign="middle" >2 (2.2)</td><td align="center" valign="middle" >8 (4.7)</td><td align="center" valign="middle" >0.33</td></tr><tr><td align="center" valign="middle" >Tobacco Use</td><td align="center" valign="middle" >6 (2.7)</td><td align="center" valign="middle" >4 (10.8)</td><td align="center" valign="middle" >0.02</td></tr><tr><td align="center" valign="middle" >Primary Source of Drugs, N (%)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Open Market</td><td align="center" valign="middle" >49 (96.1)</td><td align="center" valign="middle" >2 (3.9)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Hospital/Pharmacy</td><td align="center" valign="middle" >203 (96.2)</td><td align="center" valign="middle" >8 (3.8)</td><td align="center" valign="middle" >0.95</td></tr></tbody></table></table-wrap><p>*Fisher’s Exact Test.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Correlates of proteinuria and significant proteinuria</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Characteristic</th><th align="center" valign="middle" >Proteinuria r (p-value)</th></tr></thead><tr><td align="center" valign="middle" >Age</td><td align="center" valign="middle" >0.01 (0.88)</td></tr><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle" >0.01 (0.84)</td></tr><tr><td align="center" valign="middle" >Body Mass Index</td><td align="center" valign="middle" >−0.12 (0.06)</td></tr><tr><td align="center" valign="middle" >Systolic Pressure</td><td align="center" valign="middle" >−0.04 (0.56)</td></tr><tr><td align="center" valign="middle" >Diastolic Pressure</td><td align="center" valign="middle" >−0.17 (0.01)</td></tr><tr><td align="center" valign="middle" >Glucose, mg/dL</td><td align="center" valign="middle" >−0.00 (0.97)</td></tr><tr><td align="center" valign="middle" >Current Tobacco Use</td><td align="center" valign="middle" >0.15 (0.02)</td></tr><tr><td align="center" valign="middle" >Current Alcohol Use</td><td align="center" valign="middle" >0.06 (0.33)</td></tr><tr><td align="center" valign="middle" >Source of Drugs (1 Market, 2 Pharmacy/Hospital)</td><td align="center" valign="middle" >−0.00 (0.97)</td></tr></tbody></table></table-wrap></sec></sec><sec id="s4"><title>4. Discussions</title><p>Proteinuria is one of the most potent predictors of renal injury and chronic renal impairment [<xref ref-type="bibr" rid="scirp.92862-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref2">2</xref>]. The index study explored the frequency of early morning proteinuria defined as one or more pluses of protein in dipstick testing in the community. The prevalence of significant proteinuria was 3.8%. It peaked at 40 - 49 years and positively correlated with tobacco use and lower diastolic blood pressure.</p><p>The prevalence of significant proteinuria in this study is similar to a prevalence of 4.3%, 6.6% and 6.3% reported by previous studies. [<xref ref-type="bibr" rid="scirp.92862-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref28">28</xref>]. Generally, it has been estimated that about 5% of the general population would develop proteinuria, 15% of whom who may develop renal disease [<xref ref-type="bibr" rid="scirp.92862-ref15">15</xref>]. Though dipstick testing for proteinuria has been considered a non-cost effective way of screening for renal disease in some studies it remains a cheap and cost effective approach to investigating renal disease in the tropics [<xref ref-type="bibr" rid="scirp.92862-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref12">12</xref>]. One major drawback in screening for proteinuria in adults is the very high prevalence of possible causes [<xref ref-type="bibr" rid="scirp.92862-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref13">13</xref>]. These include common infections such as malaria as well as urinary tract infections in the elderly. Few studies have actually studied the prevalence and distribution of proteinuria in adults Nigerians, most of which were conducted on a mixed population of adolescents and adults. In one study conducted among undergraduates in northern Nigeria, the prevalence of proteinuria was as high as 20.2% [<xref ref-type="bibr" rid="scirp.92862-ref19">19</xref>]. Other Nigerian studies have reported high rates of 19% to 29.7% also [<xref ref-type="bibr" rid="scirp.92862-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref30">30</xref>]. In Argentina, a prevalence of 21.8% was reported among Toba aborigines [<xref ref-type="bibr" rid="scirp.92862-ref31">31</xref>] while a total of 1.07% was reported in a multiracial Asian Southeast Asian Community in Singapore [<xref ref-type="bibr" rid="scirp.92862-ref22">22</xref>]. Reasons for wide ranges reported in these studies may be attributed to the prevalence of risk factors, age of the population studied as well as methodological differences considering the numerous possible causes of proteinuria. Ulasi et al. [<xref ref-type="bibr" rid="scirp.92862-ref16">16</xref>] did not find any correlation between proteinuria and blood pressure and body mass in dex. Similar to a study from China proteinuria was significantly higher in smokers [<xref ref-type="bibr" rid="scirp.92862-ref5">5</xref>].</p><p>In the index study, significant proteinuria was not significantly higher among individuals with disorders that are traditionally regarded as risk factors for proteinuria. The reason for this may not be so clear considering the limitations of the present survey but one possible reason may be the inclusion of all reported cases irrespective of the duration of the illness and treatment status. However, it is interesting to note that when trace proteinuria is taken into consideration, the prevalence of proteinuria in these individuals exceeded the average 89.7% obtained for the whole population (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The relationship between some of the diseases listed in <xref ref-type="fig" rid="fig2">Figure 2</xref> (arthritis and abdominal pains) and proteinuria may lie in the frequent use of non-steroidal anti-inflammatory agents. The use of skin lightening creams has also been implicated in the cause of proteinuria in the tropics [<xref ref-type="bibr" rid="scirp.92862-ref31">31</xref>] is similar to the index study.</p><p>The only significant correlates for proteinuria in this study were smoking and lower DBP. The relationship between smoking and proteinuria in both people with or without diabetes has been well documented [<xref ref-type="bibr" rid="scirp.92862-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref33">33</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref34">34</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref35">35</xref>]. Cigarette smoke-induced renal damage is due, at least in part, to activation of the sympathetic nervous system resulting in an elevation in blood pressure [<xref ref-type="bibr" rid="scirp.92862-ref3">3</xref>]. Other factors such as renal elimination of nicotine and the presence of heavy metals in tobacco have been suggested [<xref ref-type="bibr" rid="scirp.92862-ref34">34</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref35">35</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.92862-ref37">37</xref>]. The relationship between proteinuria lower diastolic blood pressure in the index study might be an indirect reflection of the strong negative correlation between DBP and smoking</p><p>(r = −0.196, p = 0.001). Smokers are more prone to alcohol abuse and possibly not eat well especially if one takes into consideration thesocioeconomic environment where our study was carried out.</p></sec><sec id="s5"><title>5. Limitations</title><p>This study has some limitations. Firstly, causes of proteinuria are likely to be many, transient and unrelated to kidney disease in community-based studies like ours. Urine samples were collected at home without supervision. It is possible that some of the participants may not have followed previously outlined instructions. Although the study sought to differentiate common medical cases that may cause proteinuria, most of these cases were self-reported and were not confirmed using previous medical notes. Dip-stick testing only provides qualitative and not quantitative estimates of proteinuria. Notwithstanding these shortcomings, this study is one of the few community-based surveys of the prevalence of proteinuria among adults in Nigeria. The results may well be representative in poor neighborhoods of Enugu and can be reasonably used as base for further studies.</p></sec><sec id="s6"><title>6. Conclusion</title><p>The prevalence of significant early morning proteinuria in a community-based study in Enugu was 3.8%. Significant correlates of proteinuria included low diastolic blood pressure and tobacco use. Community based awareness programs targeted at prevention of chronic renal diseases should be incorporated in public health programs.</p></sec><sec id="s7"><title>Acknowledgements</title><p>The project described was supported by the Medical Education Partnership Initiative in Nigeria (MEPIN) project funded by Fogarty International Center, the Office of AIDS Research, and the National Human Genome Research Institute of the National Institute of Health, the Health Resources and Services Administration (HRSA) and the Office of the U.S. Global AIDS Coordinator under Award Number R24TW008878. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s9"><title>Cite this paper</title><p>Onodugo, O., Ezeala-Adikaibe, B.A., Orjioke, C., Onodugo, P.N., Ijoma, U.N., Chime, P., Mbadiwe, N., Onyekonwu, C., Anyim, O.B., Obumneme-Anyim, I.N., Young, E., Nwatu, C.B., Okoye, J.U. and Nwobodo, M.U. (2019) Factors Associated with Asymptomatic Proteinuria in Adult Nigerians. A Community-Based Study. Health, 11, 609-620. https://doi.org/10.4236/health.2019.116051</p></sec></body><back><ref-list><title>References</title><ref id="scirp.92862-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Carrol, M.F. and Tente, J.L. (2000) Proteinuria in Adults: A Diagnostic Approach. American Family Physician, 62, 1333-1340.</mixed-citation></ref><ref id="scirp.92862-ref2"><label>2</label><mixed-citation publication-type="book" xlink:type="simple">Bradly, H.R., O’Meara, Y.M. and Brenner, B.M. (2005) Glomerular Disease. In: Kasper, D.L., Braunwald, E., Fauci, A.S., Hauser, S.L., Longo, D.L. and Jameson, J.L., Eds., Harrison’s Principles of Internal Medicine, 16th Edition, McGraw-Hill Medical Publishing, New York, 1692-1694.</mixed-citation></ref><ref id="scirp.92862-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cooper</surname><given-names> R.G. </given-names></name>,<etal>et al</etal>. (<year>2006</year>)<article-title>Effect of Tobacco Smoking on Renal Function</article-title><source> Indian Journal of Medical Research</source><volume> 124</volume>,<fpage> 261</fpage>-<lpage>268</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.92862-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Hsu, C.C., Hwang, S.J.J., Tai, T.Y., Chen, T., Huang, M.C., Shin, S.J., Wen, C.P., Shih, Y.T., Yang, H.J., Chang, C.T., Chang, C.T., Loh, C.H., Fuh, M.T., Li, Y.S. and Chang, H.Y. (2010) Cigarette Smoking and Proteinuria in Taiwanese Men with Type 2 Diabetes Mellitus. Diabetic Medicine, 27, 295-302.  
https://doi.org/10.1111/j.1464-5491.2010.02947.x</mixed-citation></ref><ref id="scirp.92862-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Chen, W., Wang, H., Dong, D., Liu, Q., Mao, H., Tan, J., Lin, J., Zhou, F., Luo, N., He, H., Johnson, J.R., Zhou, S.-F. and Yu, X. (2009) Prevalence and Risk Factors Associated with Chronic Kidney Disease in an Adult Population from Southern China. Nephrology Dialysis and Transplantation, 24, 1205-1212.  
https://doi.org/10.1093/ndt/gfn604</mixed-citation></ref><ref id="scirp.92862-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Perkovic, V., Verdon, C., Ninomiya, T., Barzi, F., Cass, A., Patel, A., Jardine, M., Gallagher, M., Turnbull, F., Chalmers, J., Craig, J. and Huxley, R. (2008) The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis. PLoS Medicine, 5, e207. https://doi.org/10.1371/journal.pmed.0050207</mixed-citation></ref><ref id="scirp.92862-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Ong, L.M., Punithayathi, N., Thurairatnam, D., Zainal, H., Beh, M.L., Morad, Z., Lee, S.Y., Bavanandan, S. and Kok, L.S. (2013) Prevalence and Risk Factors for Proteinuria: The National Kidney Foundation of Malaysia Life Check Health Screening Programme. Nephrology (Carlton), 18, 569-575.  
https://doi.org/10.1111/nep.12112</mixed-citation></ref><ref id="scirp.92862-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Price, C.P., Newall, R.G. and Boyd, J.C. (2005) Use of Protein: Creatinine Ratio Measurements on Random Urine Samples for Prediction of Significant Proteinuria: A Systematic Review. Clinical Chemistry, 51, 1577-1586.  
https://doi.org/10.1373/clinchem.2005.049742</mixed-citation></ref><ref id="scirp.92862-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Bacquer, D.D. and Vanholder, R. (2005) Chronic Kidney Disease: A European Perspective. Kidney International Supplement, No. 99, S30-S38.  
https://doi.org/10.1111/j.1523-1755.2005.09907.x</mixed-citation></ref><ref id="scirp.92862-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">National Kidney Foundation (2002) KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification Part 9. Approach to Chronic Kidney Disease Using These Guidelines.</mixed-citation></ref><ref id="scirp.92862-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Boulware, L.E., Jaar, B.G., Tarver-Carr, M.E., Brancati, F.L. and Powe, R.N. (2003) Screening for Proteinuria in US Adults: A Cost-Effective Analysis. Journal of American Medical Association, 290, 3101-3114.  
https://doi.org/10.1001/jama.290.23.3101</mixed-citation></ref><ref id="scirp.92862-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">El-Tayeb, M., El Setouhy, M., El Sayed, H., Elshahawy, Y., Sany, D., Bichari, W. and Shaban, A. (2010) Screening of Proteinuria in Young Adults: Is It Worthwhile? Dialysis &amp; Transplantation, 12, 522-526. https://doi.org/10.1002/dat.20516</mixed-citation></ref><ref id="scirp.92862-ref13"><label>13</label><mixed-citation publication-type="book" xlink:type="simple">Goddard, J., Turner, A.M.N. and Stewart, L.H. (2010) Kidney and Urinary Tract Disease. In: Colledge, N.R., Walker, B.R. and Ralston, S.H., Eds., Davidson’s Principle and Practice of Medicine, Churchill Livingstone Elsevier, London, 21st Edition, 480-481.</mixed-citation></ref><ref id="scirp.92862-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Rosas, M., Attie, F., Pastelin, G., Lara, A., Velazquez, O., Tapia-Conyer, R., Martinez-Reding, J., Mendez, A., Lorenzo-Negrete, A. and Herrera-Acosta, J. (2005) Prevalence of Proteinuria in Mexico: A Conjunctive Consolidation Approach with Other Cardiovascular Risk Factors: The Mexican Health Survey 2000. Kidney International, 68, S112-S119. https://doi.org/10.1038/ki.2005.4496239</mixed-citation></ref><ref id="scirp.92862-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">The CARI Guidelines (2004) Urine Protein as Diagnostic Test: Testing for Proteinuria. Caring for Australians with Renal Impairment (CARI). Nephrology (Carlton), 9, S3-S7.</mixed-citation></ref><ref id="scirp.92862-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Ulasi, I., Arogundade, F.A., Aderibigbe, A., Oviasu, E., Akinsola, A., Arije, A., Ijoma, C.K., Anteyi, E.A., Ajayi, S., Manvem, M., Adeniyi, A.B., Mbah, I., Salako, B.L., Sanusi, A.A., Angbarzo, I. and Kwaifa, A.S. on Behalf of the National Kidney Disease Awareness and Sensitization Implementation Committee (2006) Assessment of Risk Factors for Kidney Disease in an Unselected Population of Nigerians: A Report of the Routine Screening Conducted during the National Kidney Disease Awareness and Sensitization Programme Organized by Nigerian Association of Nephrology (NAN). Tropicai loumai cf Neptirotoqy, 1, 73-80.</mixed-citation></ref><ref id="scirp.92862-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Arogundade, F., Sanusi, Hassan, M., Gbadegesin, A., Olarinoye, F., Otuyemi, B. and Akinsola, A. (2011) Undiagnosed Hypertension and Proteinuria in a Market Population in Ile-Ife, Nigeria. Arab Journal of Nephrology and Transplantation, 4, 141-146. https://doi.org/10.4314/ajnt.v4i3.71026</mixed-citation></ref><ref id="scirp.92862-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Abene, E.E., Gimba, Z.M., Agaba, P.A., Uchendu, D.G., Olaniru, O.B., Ocheke, I.E. and Agaba, E.I. (2017) Chronic Kidney Disease Screening: Results of the 2013 World Kidney Day Activities Conducted at the Jos University Teaching Hospital. Highland Medical Research Journal, 17, 1-5.</mixed-citation></ref><ref id="scirp.92862-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Musa, A.H., Gali, R.M., Mamza, Y.P. and Babazau, L. (2018) Prevalence of Isolated Proteinuria in Students of University of Maiduguri, Borno State Nigeria: An Early Indicator of Renal Insufficiency. Research and Reports in Medical Sciences, 2, 105.</mixed-citation></ref><ref id="scirp.92862-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Shah, V.N., Cheema, B.C., Iyengar, S., Khullar, M., Kohli, H.S. and Bhansali, A. (2015) Risk Factors for Proteinuria and Renal Insufficiency in Asian Indian Patients with Type 2 Diabetes. International Journal of Diabetes in Developing Countries, 35, 554-558. https://doi.org/10.1007/s13410-015-0338-8</mixed-citation></ref><ref id="scirp.92862-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Garg, A.X., Kiberd, B.A., Clark, W.F., Haynes, R.B. and Clase, C.M. (2002) Albuminuria and Renal Insufficiency Prevalence Guides Population Screening: Results from the NHANES Ill. Kidney International, 61, 2165-2221.  
https://doi.org/10.1046/j.1523-1755.2002.00356.x</mixed-citation></ref><ref id="scirp.92862-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Ramirez, S.R., McClellan, W., Port, F.K. and Hsu, S.I. (2002) Risk Factors for Proteinuria in a Large, Multiracial, Southeast Asian Population. Journal of the American Society of Nephrology, 13, 1907-1917.  
https://doi.org/10.1097/01.ASN.0000018406.20282.C8</mixed-citation></ref><ref id="scirp.92862-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Chadban, S.J., Briganti, E.M., Kerr, P.G., Dunstan, D.W., Welborn, T.A., Zimmet, P.Z. and Atkins, R.C. (2003) Prevalence of Kidney Damage in Australian Adults: The AusDiab Kidney Study. Journal of American Society of Nephrology, 14, S131-S138. https://doi.org/10.1097/01.ASN.0000070152.11927.4A</mixed-citation></ref><ref id="scirp.92862-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Li, P.K., Kwan, B.C., Leung, C.B., Kwan, T.H., Wong, K.M., Lui, S.I., Tsang, W.K., Mak, C.C., Mak, S.K., Yu, A.W., Tang, S. and Hong Kong Society of Nephrology (2005) Prevalence of Silent Kidney Disease in Hong Kong: The Screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) Program. Kidney International, 67, S36-S40. https://doi.org/10.1111/j.1523-1755.2005.09410.x</mixed-citation></ref><ref id="scirp.92862-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Ezeala-Adikaibe, B.A., Mbadiwe, N., Okwara, C., Onodugo, O., Onyekonwu, C., Ijoma, U., Ekenze, O.S., Orjioke, C., Chime, P., Aneke, E., Nwatu, C.B., Young, E. and Anyim, O. (2018) Diabetes and Pre-Diabetes among Adults in an Urban Slum in South East Nigeria. Journal of Diabetes Mellitus, 8, 131-144.  
https://doi.org/10.4236/jdm.2018.84013</mixed-citation></ref><ref id="scirp.92862-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Cochran, W.G. (1963) Sampling Techniques. 2nd Edition, John Wiley &amp; Sons, Inc., New York.</mixed-citation></ref><ref id="scirp.92862-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Winocour, P.H., Harland, J., Millar, J.P., Laker, M.F. and Alberti, K.G.M.M. (1992) Microalbuminuria and Associated Risk Factors in the Community. Atherosclerosis, 93, 71-81. https://doi.org/10.1016/0021-9150(92)90201-Q</mixed-citation></ref><ref id="scirp.92862-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Ulasi, I., Ijoma, C.K., Onwubere, J.C., Arodiwe, E., Onodugo, O. and Okafor, C. (2011) High Prevalence and Low Awareness of Hypertension in a Market Population in Enugu Nigeria. International Journal of Hypertension, 2011, Article ID: 869675. https://doi.org/10.4061/2011/869675</mixed-citation></ref><ref id="scirp.92862-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Nalado, A.M., Abdu, A., Muhammad, H., Abdu, A., Sakajiki, A.M. and Adamu, B. (2012) Prevalence of Risk Factors for Chronic Kidney Disease among Civil Servants in Kano. Nigerian Journal of Basic and Clinical Sciences, 2, 70-74.  
https://doi.org/10.4103/0331-8540.108467</mixed-citation></ref><ref id="scirp.92862-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Wakoma, F.S. and Emem-Chioma, P.C. (2010) Prevalence of Risk Factors for Chronic Kidney Disease in a Rural Adult Population in Rivers State. Tropical Journal of Nephrology, 5, 70.</mixed-citation></ref><ref id="scirp.92862-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Ulasi, I.I., Ijoma, C.K. and Kalu, O.A. (2005) A Etiological Relationship between Nephrotic Syndrome and Mercury Containing Skin Lightning Creams and Medicated Soaps. Nigerian Medical Journal, 2, 29-32.</mixed-citation></ref><ref id="scirp.92862-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Noborisaka, Y., Ishizaki, M., Nakata, M., Yamada, Y., Honda, R., Yokoyama, H., Miyao, M. and Tabata, M. (2012) Cigarette Smoking, Proteinuria, and Renal Function in Middle-Aged Japanese Men from an Occupational Population. Environmental Health and Preventive Medicine, 17, 147-156.  
https://doi.org/10.1007/s12199-011-0234-x</mixed-citation></ref><ref id="scirp.92862-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Hitesh, S. (2005) Incidence of Microalbuminuria in Tobacco Chewers. Indian Journal of Clinical Biochemistry, 20, 189-191. https://doi.org/10.1007/BF02867426</mixed-citation></ref><ref id="scirp.92862-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Orth, S.R. (2002) Cigarette Smoking: An Important Renal Risk Factor-Far beyond Carcinogenesis. Tobacco Induced Diseases, 1, 137-155.  
https://doi.org/10.1186/1617-9625-1-2-137</mixed-citation></ref><ref id="scirp.92862-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Orth, S.R. (2002) Smoking and the Kidney. Journal of the American Society of Nephrology, 13, 1663-1672. https://doi.org/10.1097/01.ASN.0000018401.82863.FD</mixed-citation></ref><ref id="scirp.92862-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Addo, M.A., Gbadago, J.K., Affum, H.A., Adom, T., Ahmed, K. and Okley, G.M. (2008) Mineral Profile of Ghanaian Dried Tobacco Leaves and Local Snuff: A Comparative Study. Journal of Radioanalytical and Nuclear Chemistry, 277, 517-524.  
https://doi.org/10.1007/s10967-007-7054-x</mixed-citation></ref><ref id="scirp.92862-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Usunobun, U., Adegbeg, J., Ademuyiwa, O., Okugbo, T.F., Evuen, U., Osibemhe, M. and Okolie, N.P. (2012) Nnitrosodimethylamine (NDMA), Liver Function Enzymes, Renal Function Parameters and Oxidative Stress Parameters: A Review. British Journal of Pharmacology and Toxicology, 3, 165-176.</mixed-citation></ref></ref-list></back></article>